• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

体外测定 APE1 对核糖单磷酸无碱基位点的酶活性。

In Vitro Assay to Measure APE1 Enzymatic Activity on Ribose Monophosphate Abasic Site.

机构信息

Laboratory of Molecular Biology and DNA repair, Department of Medicine (DAME), University of Udine, Udine, Italy.

出版信息

Methods Mol Biol. 2023;2701:21-38. doi: 10.1007/978-1-0716-3373-1_2.

DOI:10.1007/978-1-0716-3373-1_2
PMID:37574473
Abstract

APE1 (apurinic/apyrimidinic endodeoxyribonuclease 1) is a central enzyme of the base excision repair (BER) pathway playing a pivotal role in protecting mammalian cells against genotoxins and in safeguarding genome stability. Recently, we demonstrated the APE1 ability to process abasic ribonucleotides embedded in DNA. Here, we provide a pipeline of protocols to quantify endodeoxyribonuclease activity by APE1 on these substrates, by using recombinant protein and whole-cell extracts. The repair capacity is measured by using fluorescent oligonucleotide substrates, which are then separated by polyacrylamide gel electrophoresis and detected by imaging scanning. The specificity of APE1 action is demonstrated using specific APE1 enzymatic inhibitors.

摘要

APE1(脱嘌呤/脱嘧啶核酸内切酶 1)是碱基切除修复(BER)途径的核心酶,在保护哺乳动物细胞免受遗传毒素和维持基因组稳定性方面发挥着关键作用。最近,我们证明了 APE1 能够处理嵌入 DNA 中的碱基缺失核糖核苷酸。在这里,我们提供了一个使用重组蛋白和全细胞提取物来定量 APE1 对这些底物进行内切核酸酶活性的方案。通过使用荧光寡核苷酸底物来测量修复能力,然后通过聚丙烯酰胺凝胶电泳将其分离,并通过成像扫描进行检测。通过使用特定的 APE1 酶抑制剂来证明 APE1 作用的特异性。

相似文献

1
In Vitro Assay to Measure APE1 Enzymatic Activity on Ribose Monophosphate Abasic Site.体外测定 APE1 对核糖单磷酸无碱基位点的酶活性。
Methods Mol Biol. 2023;2701:21-38. doi: 10.1007/978-1-0716-3373-1_2.
2
APE1 condensation in nucleoli of non-cancer cells depends on rRNA transcription and forming G-quadruplex RNA structures.非癌细胞核仁中的脱嘌呤/脱嘧啶核酸内切酶1(APE1)凝聚取决于核糖体RNA(rRNA)转录并形成G-四链体RNA结构。
Nucleic Acids Res. 2025 Feb 27;53(5). doi: 10.1093/nar/gkaf168.
3
Nucleolytic processing of abasic sites underlies PARP inhibitor hypersensitivity in ALC1-deficient BRCA mutant cancer cells.碱基切除修复缺陷的 BRCA 突变型癌细胞中,无碱基位点的核酸内切酶加工是 PARP 抑制剂超敏反应的基础。
Nat Commun. 2024 Jul 27;15(1):6343. doi: 10.1038/s41467-024-50673-7.
4
Explainable AI-driven prediction of APE1 inhibitors: enhancing cancer therapy with machine learning models and feature importance analysis.可解释人工智能驱动的APE1抑制剂预测:利用机器学习模型和特征重要性分析增强癌症治疗
Mol Divers. 2025 Feb 21. doi: 10.1007/s11030-025-11133-6.
5
Global screening of base excision repair in nucleosome core particles.核小体核心颗粒碱基切除修复的全球筛选。
DNA Repair (Amst). 2024 Dec;144:103777. doi: 10.1016/j.dnarep.2024.103777. Epub 2024 Oct 19.
6
AP endonuclease 1: Biological updates and advances in activity analysis.AP 内切酶 1:生物学更新和活性分析进展。
Methods Enzymol. 2024;705:347-376. doi: 10.1016/bs.mie.2024.07.011. Epub 2024 Sep 5.
7
APE1 is a master regulator of the ATR-/ATM-mediated DNA damage response.脱嘌呤/脱嘧啶核酸内切酶1(APE1)是ATR/ATM介导的DNA损伤反应的主要调节因子。
DNA Repair (Amst). 2024 Dec;144:103776. doi: 10.1016/j.dnarep.2024.103776. Epub 2024 Oct 19.
8
Chemically induced partial unfolding of the multifunctional apurinic/apyrimidinic endonuclease 1.化学诱导多功能脱嘌呤/脱嘧啶核酸内切酶1的部分去折叠
Protein Sci. 2025 Jun;34(6):e70148. doi: 10.1002/pro.70148.
9
Unfilled gaps by polβ lead to aberrant ligation by LIG1 at the downstream steps of base excision repair pathway.在碱基切除修复途径的下游步骤中,polβ留下的未填补缺口会导致LIG1进行异常连接。
Nucleic Acids Res. 2024 Apr 24;52(7):3810-3822. doi: 10.1093/nar/gkae104.
10
AUF1 Recognizes 8-Oxo-Guanosine Embedded in DNA and Stimulates APE1 Endoribonuclease Activity.AUF1 识别嵌入 DNA 中的 8-氧鸟嘌呤核苷并刺激 APE1 内切核酸酶活性。
Antioxid Redox Signal. 2023 Sep;39(7-9):411-431. doi: 10.1089/ars.2022.0105. Epub 2023 Apr 11.

本文引用的文献

1
Coping with RNA damage with a focus on APE1, a BER enzyme at the crossroad between DNA damage repair and RNA processing/decay.应对 RNA 损伤的策略:聚焦 APE1,BER 酶在 DNA 损伤修复和 RNA 加工/降解的交汇点。
DNA Repair (Amst). 2021 Aug;104:103133. doi: 10.1016/j.dnarep.2021.103133. Epub 2021 May 13.
2
RNA abasic sites in yeast and human cells.酵母和人类细胞中的 RNA 无碱基位点。
Proc Natl Acad Sci U S A. 2020 Aug 25;117(34):20689-20695. doi: 10.1073/pnas.2011511117. Epub 2020 Aug 11.
3
New perspectives in cancer biology from a study of canonical and non-canonical functions of base excision repair proteins with a focus on early steps.
从碱基切除修复蛋白的经典和非经典功能研究中获得癌症生物学的新视角,重点关注早期步骤。
Mutagenesis. 2020 Feb 13;35(1):129-149. doi: 10.1093/mutage/gez051.
4
Abasic and oxidized ribonucleotides embedded in DNA are processed by human APE1 and not by RNase H2.嵌入DNA中的无碱基和氧化核糖核苷酸由人类APE1处理,而非由核糖核酸酶H2处理。
Nucleic Acids Res. 2017 Nov 2;45(19):11193-11212. doi: 10.1093/nar/gkx723.
5
Inhibitors of the apurinic/apyrimidinic endonuclease 1 (APE1)/nucleophosmin (NPM1) interaction that display anti-tumor properties.具有抗肿瘤特性的脱嘌呤/脱嘧啶核酸内切酶1(APE1)/核磷蛋白(NPM1)相互作用抑制剂。
Mol Carcinog. 2016 May;55(5):688-704. doi: 10.1002/mc.22313. Epub 2015 Apr 11.
6
Purification and specific assays for measuring APE-1 endonuclease activity.用于测量APE-1核酸内切酶活性的纯化及特异性检测方法。
Methods Mol Biol. 2012;928:161-74. doi: 10.1007/978-1-62703-008-3_13.
7
RNase H2-initiated ribonucleotide excision repair.RNA 酶 H2 起始的核苷酸切除修复。
Mol Cell. 2012 Sep 28;47(6):980-6. doi: 10.1016/j.molcel.2012.06.035. Epub 2012 Aug 2.
8
Synthesis, biological evaluation, and structure-activity relationships of a novel class of apurinic/apyrimidinic endonuclease 1 inhibitors.新型嘌呤/嘧啶内切核酸酶 1 抑制剂的合成、生物评价及构效关系研究。
J Med Chem. 2012 Apr 12;55(7):3101-12. doi: 10.1021/jm201537d. Epub 2012 Mar 28.
9
Intrusion of a DNA repair protein in the RNome world: is this the beginning of a new era?DNA 修复蛋白侵入 RNA 世界:这是否是新时代的开始?
Mol Cell Biol. 2010 Jan;30(2):366-71. doi: 10.1128/MCB.01174-09. Epub 2009 Nov 9.
10
Identification and characterization of inhibitors of human apurinic/apyrimidinic endonuclease APE1.人脱嘌呤/脱嘧啶核酸内切酶APE1抑制剂的鉴定与表征
PLoS One. 2009 Jun 1;4(6):e5740. doi: 10.1371/journal.pone.0005740.